OrganiGram Holdings Company Executives
| OGI Stock | CAD 2.59 0.05 1.89% |
OrganiGram Holdings employs about 984 people. The company is managed by 26 executives with a total tenure of roughly 95 years, averaging almost 3.0 years of service per executive, having 37.85 employees per reported executive. Analysis of OrganiGram Holdings' management performance can provide insight into the firm performance.
OrganiGram |
OrganiGram Holdings Management Team Effectiveness
The company has return on total asset (ROA) of (0.0556) % which means that it has lost $0.0556 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5453) %, meaning that it generated substantial loss on money invested by shareholders. OrganiGram Holdings' management efficiency ratios could be used to measure how well OrganiGram Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of May 2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.08. At this time, OrganiGram Holdings' Intangible Assets are very stable compared to the past year. As of the 3rd of May 2024, Intangibles To Total Assets is likely to grow to 0.10, while Net Tangible Assets are likely to drop about 290.2 M.As of the 3rd of May 2024, Common Stock Shares Outstanding is likely to grow to about 373 M, while Net Loss is likely to drop (13.5 M).
OrganiGram Holdings Workforce Comparison
OrganiGram Holdings is considered to be number one stock in number of employees category among related companies. The total workforce of Health Care industry is now estimated at about 8,261. OrganiGram Holdings retains roughly 984 in number of employees claiming about 12% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.54) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.44) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.44. OrganiGram Holdings Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. OrganiGram Holdings Price Series Summation is a cross summation of OrganiGram Holdings price series and its benchmark/peer.
OrganiGram Holdings Notable Stakeholders
An OrganiGram Holdings stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as OrganiGram Holdings often face trade-offs trying to please all of them. OrganiGram Holdings' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting OrganiGram Holdings' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gregory Engel | Chief Executive Officer, Director | Profile | |
| Helen Martin | Senior Vice President, Strategic, Legal Affairs Corporate Secretary | Profile | |
| Jeffrey Purcell | Senior Vice President - Operations Services | Profile | |
| Derrick West | Chief Financial Officer | Profile | |
| Paolo Luca | Chief Financial Officer | Profile | |
| Max Schwartz | Director Relations | Profile | |
| James Cavanagh | Chief of Staff | Profile | |
| Katrina McFadden | Chief Officer | Profile | |
| Peter West | Director | Profile | |
| Megan McCrae | Senior Communications | Profile | |
| Amy Schwalm | Vice President of Investor Relations | Profile | |
| Matthew Rogers | Vice President - Operations | Profile | |
| CFA CA | Chief Officer | Profile | |
| Julie Chamberlain | Vice President of Marketing | Profile | |
| Dexter John | Independent Director | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Beena Goldenberg | CEO Director | Profile | |
| Michel Bourque | Independent Director | Profile | |
| Raymond Gracewood | Senior Vice President of Marketing and Communications | Profile | |
| Tina Shannon | VP HR | Profile | |
| Peter Amirault | Independent Chairman of the Board | Profile | |
| Nathalie Batten | Senior Operations | Profile | |
| Timothy Emberg | Senior Vice President - Sales and Commercial Operations | Profile | |
| Cameron Bishop | Vice President of Public Affairs and Stakeholder Relations | Profile | |
| Geoff Riggs | Chief Officer | Profile | |
| Sherry Porter | Independent Director | Profile |
About OrganiGram Holdings Management Performance
The success or failure of an entity such as OrganiGram Holdings often depends on how effective the management is. OrganiGram Holdings management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of OrganiGram management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the OrganiGram management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.03) | (0.03) | |
| Return On Capital Employed | (0.07) | (0.08) | |
| Return On Assets | (0.02) | (0.03) | |
| Return On Equity | (0.03) | (0.03) |
The data published in OrganiGram Holdings' official financial statements usually reflect OrganiGram Holdings' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of OrganiGram Holdings. For example, before you start analyzing numbers published by OrganiGram accountants, it's critical to develop an understanding of what OrganiGram Holdings' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of OrganiGram Holdings' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, OrganiGram Holdings' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in OrganiGram Holdings' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of OrganiGram Holdings. Please utilize our Beneish M Score to check the likelihood of OrganiGram Holdings' management manipulating its earnings.
OrganiGram Holdings Workforce Analysis
Traditionally, organizations such as OrganiGram Holdings use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare OrganiGram Holdings within its industry.OrganiGram Holdings Manpower Efficiency
Return on OrganiGram Holdings Manpower
| Revenue Per Employee | 148.2K | |
| Revenue Per Executive | 5.6M | |
| Net Loss Per Employee | 233.2K | |
| Net Loss Per Executive | 8.8M | |
| Working Capital Per Employee | 169K | |
| Working Capital Per Executive | 6.4M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for OrganiGram Stock analysis
When running OrganiGram Holdings' price analysis, check to measure OrganiGram Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OrganiGram Holdings is operating at the current time. Most of OrganiGram Holdings' value examination focuses on studying past and present price action to predict the probability of OrganiGram Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OrganiGram Holdings' price. Additionally, you may evaluate how the addition of OrganiGram Holdings to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |